(Q36269492)

English

The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

A D Genazzani

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

C Battaglia

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

O Gamba

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

F Petraglia

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

B Malavasi

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

A R Genazzani

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

1 May 2000

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Assisted Reproduction and Genetics

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

17

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

269-275

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

30 September 2017

The polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

30 September 2017

Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

30 September 2017

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

30 September 2017

Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Estimation of instantaneous secretory rate of luteinizing hormone in women during the menstrual cycle and in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

Use of the receiver operating characteristic curve to evaluate sensitivity, specificity, and accuracy of methods for detection of peaks in hormone time series.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

29 June 2018

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455206

22 September 2018

Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term GnRH-agonist administration revealed a GnRHindependent mechanism stimulating FSH discharge in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finasteride in the treatment of hirsutism: new therapeutic perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulsatile luteinizing hormone secretion pattern in hyperandrogenemic women

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The concomitant release of androstenedione with Cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrinology: Evidence suggesting an additional control mechanism regulating episodic secretion of luteinzing hormone and follicle stimulating hormone in pre-pubertal children and post-menopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10976414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1009410416638

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36269492&oldid=2198509471"